Article Abstract

Ebola virus and persistent chronic infection: when does replication cease?

Authors: John V. Forrester

Abstract

In this issue of the journal, Shantha et al. report a series
of cataract surgeries on survivors of Ebola virus (EBOV)
infection. EBOV, originally identified as a new pathogen in
1976 during an outbreak of haemorrhagic fever in Zaire (1),
is a highly virulent organism associated with a mortality
rate ranging from 50 to nearly 90% [reviewed in (2)].